Health Care Providers' Views on Clinic Infrastructure and Practice Models That May Facilitate HIV Preexposure Prophylaxis (PrEP) Prescribing: A Qualitative Meta-Synthesis.

HIV preexposure prophylaxis (PrEP) HIV/AIDS access to care clinic infrastructure environmental and systems change health care providers practice models prescribing

Journal

Health promotion practice
ISSN: 1524-8399
Titre abrégé: Health Promot Pract
Pays: United States
ID NLM: 100890609

Informations de publication

Date de publication:
11 2022
Historique:
pubmed: 23 9 2021
medline: 3 12 2022
entrez: 22 9 2021
Statut: ppublish

Résumé

HIV (human immunodeficiency virus) preexposure prophylaxis (PrEP) is an effective biomedical HIV prevention tool. Increasing PrEP use among populations disproportionately affected by HIV is one of the key efforts in the United States' Ending the HIV Epidemic (EHE) initiative and the HIV National Strategic Plan for the United States. Given that PrEP is available only through prescription, it is important to explore structural, organizational, or environmental factors that could facilitate or impede health care provider's PrEP prescribing behavior. The purpose of this systematic review (PROSPERO [CRD: 42019138889]) is to identify qualitative studies that addressed this topic and conduct meta-synthesis using the thematic synthesis method to identify major themes on the characteristics of clinic infrastructure or clinic models that providers consider as facilitators of PrEP prescribing in the United States. Eighteen citations representing 15 studies were included in this review. Five overarching themes were identified: (1) routinized HIV risk assessment; (2) interdisciplinary/coordinated PrEP teams or services; (3) clinic capacity to provide essential PrEP-related services; (4) low out-of-pocket patient costs; and (5) access to the priority populations. Some of these themes are consistent with the recommendations of CDC's PrEP clinical guidelines and the EHE initiative. More recent studies that include perspectives of diverse providers, timely analysis of these studies, and implementation research to assess strategies to address the current practice gaps are needed to further promote PrEP prescribing among providers in the United States.

Identifiants

pubmed: 34549652
doi: 10.1177/15248399211038364
pmc: PMC8938291
mid: NIHMS1759118
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

999-1014

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States

Auteurs

Yuko Mizuno (Y)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Deborah J Gelaude (DJ)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Nicole Crepaz (N)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Emiko Kamitani (E)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Julia B DeLuca (JB)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Carolyn A Leighton (CA)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Megan E Wichser (ME)

ICF International, Atlanta, GA, USA.

Dawn K Smith (DK)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH